Skip to content

Haby Henary

Haby Henary

Company: Amgen

Job title: Medical Director, Oncology Global Development

Seminars:

Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK) and Efficacy of AMG 510, a Novel, First in Class, Irreversible Inhibitor of KRASG12C 9:00 am

AMG 510 FIH study  Safety and tolerability of AMG 510 AMG 510 clinical anti tumor activityRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.